Microangiopathic hemolytic anemia

Jump to: navigation, search
Microangiopathic hemolytic anemia
ICD-10 D59.4
ICD-9 283.19
DiseasesDB 29721

Microangiopathic hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Microangiopathic hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Microangiopathic hemolytic anemia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Microangiopathic hemolytic anemia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Microangiopathic hemolytic anemia

on Microangiopathic hemolytic anemia

Microangiopathic hemolytic anemia in the news

Blogs on Microangiopathic hemolytic anemia</small>

Directions to Hospitals Treating Microangiopathic hemolytic anemia

Risk calculators and risk factors for Microangiopathic hemolytic anemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and Keywords: Microangiopathic haemolytic anaemia; MHA

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Microangiopathic hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case#1



Linked-in.jpg